Search Results 391-400 of 16272 for GLP-1 agonist
Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in Arizona, Florida and Minnesota. Staff skilled in ...
... 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market. Study IDs. Site IRB.
If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines. ... You may report side effects to ...
About this study. The purpose of this study is to collect medical and family histories, blood and/or tumor tissue samples from patients who are being tested ...
If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines. Ketoconazole. Other Interactions.
Study PT-112-102, a multicenter, open-label dose-finding and pharmacokinetic study of PT-112 in patients with relapsed or refractory multiple myeloma. This is ...
A Phase 1 Dose Escalation and Expansion Study of TGR-1202 + Ruxolitinib in Subjects with Primary Myelofibrosis (PMF), Post-Polycythemia Vera MF (PPV-MF) ...
If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines. Licorice; Saiboku-To. Other ...
The purpose of this research study is to understand the natural history of vision in patients with OPG and determine if there are factors (e.g. age at diagnosis ...
Mayo Clinic researchers have developed a genetic test that can help predict how people will respond to weight loss medications such as GLP-1s. Latest ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!